1. CIPE, Inter-Ministerial Committee for Economic Planning. Identifying criteria for contracting on the price of innovative medicines. Decree of January 30, 1997. Official Gazette. May 3, 1997.
2. Joint Government/Pharmaceutical Industry Working Party. UK guidance on good practice in the conduct of economic evaluation of medicines. Br J Med Econ. 1994;7:63–64.
3. Rovira J, Antonanzas F. Economic analysis of health technologies and programs: a Spanish proposal for methodological standardization. Pharmacoecon. 1995;7:1–6.
4. Collège des Economistes de la Santé. Guidelines and Recommendations for French Pharmaco-economic studies. CES. April 1997.
5. Alban A, Keiding H, Søgaard J. Guidelines for Socioeconomic Analyses of Pharmaceuticals. Copenhagen: Danish Ministry of Health, March 1998.